Atlas Trials

Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors

Clinical trial NCT02441062 · COMPLETED

Trial details

NCT number
NCT02441062
Sponsor
Sue O'Dorisio
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine TumorsCarcinoid TumorsNeuroblastomaMedulloblastoma
Start date
2015-09-01
Primary completion
2020-01-20
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.